Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization

Journal Title: Biomedical Journal of Scientific & Technical Research (BJSTR) - Year 2019, Vol 14, Issue 5

Abstract

Background: Transcatheter arterial chemoembolization (TACE) refractoriness is an indication for sorafenib treatment in patients with intermediate-stage hepatocellular carcinoma (HCC). This study aims at evaluating the efficacy of conversion of treatment to sorafenib on overall survival (OS) among trans arterial chemoembolization (TACE)-refractory HCC patients. Methods: This retrospective cohort study included 497 patients with HCC treated with TACE between January 2008 and December 2013 at the Kindai University Hospital. Among those patients, 56 were considered refractory to TACE. These TACE-refractory patients were grouped into two cohorts: a) patients who switched treatment from TACE to sorafenib (sorafenib group) and b) those who continued TACE (TACE group). We evaluated the OS of patients from the initial TACE.Results: Thirty-two patients were classified into the sorafenib group, while 24 patients were in the TACE group. The median OS from the initial TACE was 4.29 years in the sorafenib group and 2.14 years in the TACE group (p < 0.0010).Conclusion: Conversion of treatment to sorafenib might improve the OS in TACE-refractory patients with intermediate-stage HCC. Hence, conversion of treatment should be considered for HCC patients refractory to TACE.

Authors and Affiliations

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo

Keywords

Related Articles

The Laryngeal Mask Airway in Pediatric Anesthesia

Since the reports that the laryngeal airway mask (LMA) could be used safely and effectively in pediatric anaesthesia in 1990s [1,2], LMA are currently recommended for use in a variety of challenging scenarios, such as in...

Review on Application of Agro-Waste Biomass Biochar for Adsorption and Bioremediation Dye

This review brings the little knowledge about the effectiveness of combined bio-film and biochar approach in bio-sorption method for the removal of synthetic dye which generated from wastewater of textile and carpet indu...

Auditory Deprivation Caused By Early Otitis Media with Effusion

Introduction: In the past 40 years, the literature has attempted to clarify the evidence on the effect of early auditory deprivation caused by early otitis media with effusion (OME) on central auditory processing (CAP)....

Regulation of PD-L1 Expression by Histone Deacetylase Inhibitor SAHA in Lung Cancer Cells

The expression of PD-L1 is checkpoint indicator indicative of immunosuppression and cause for poor prognosis in several cancers. The effects of PD-L1 are mediated through its binding to the Programmed Cell Death-1 (PD-1)...

A Simple Descriptive Study of Osteoarthritis among Libyan Patients who were Examined at the Jordanian Field Hospital in Benghazi City/ Libya

Introduction: Osteoarthritis (OA) is the most common chronic arthritis impacts health parameters and quality of life. It affects old age, but it can occur in adults of any age. Objectives: To study and describe OA cases...

Download PDF file
  • EP ID EP585992
  • DOI 10.26717/BJSTR.2019.14.002610
  • Views 145
  • Downloads 0

How To Cite

Tadaaki Arizumic, Tomohiro Minami, Masatoshi Kudo (2019). Efficacy of Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization. Biomedical Journal of Scientific & Technical Research (BJSTR), 14(5), 10906-10910. https://europub.co.uk./articles/-A-585992